AME
66
4
BSX
60
3
CHRW
79
3
BIIB
46
-3
CLX
51
-2
ADM
45
-2
ADP
58
-8
AZO
45
5
ES
50
3
ADSK
62
6
AVY
54
-7
AEE
58
3
AMT
25
-5
ABBV
46
-4
AMZN
52
4
APD
47
-3
COF
67
2
A
48
8
CNX
46
-3
APA
48
-4
AME
66
4
BSX
60
3
CHRW
79
3
BIIB
46
-3
CLX
51
-2
ADM
45
-2
ADP
58
-8
AZO
45
5
ES
50
3
ADSK
62
6
AVY
54
-7
AEE
58
3
AMT
25
-5
ABBV
46
-4
AMZN
52
4
APD
47
-3
COF
67
2
A
48
8
CNX
46
-3
APA
48
-4
Financhill
Back

SPDR S&P Global Natural Resources ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
35

GNR
SPDR S&P Global Natural Resources ETF

Last Price:
$60.85
Seasonality Move:
1.98%
Sell
44

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$111.76
Seasonality Move:
-13.08%
Sell
35
SPDR S&P Global Natural Resources ETF (GNR) is a Sell

Is SPDR S&P Global Natural Resources ETF a Buy, Sell or Hold?

  • The current SPDR S&P Global Natural Resources ETF [GNR] share price is $60.86. The Score for GNR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • GNR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.73. The Score for RYTM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GNR Stock Price Chart

What is SPDR S&P Global Natural Resources ETF's stock price today?

  • The SPDR S&P Global Natural Resources ETF share price today is $60.86
    The current trend is moderately bearish and GNR is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $111.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.

GNR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 50.14 Buy
Chaikin Money Flow: -90778 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.57 - 61.91) Buy
Bollinger Bands (100): (56.78 - 60.54) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.8 Buy
Relative Strength Index (14 RSI): 56.8 Buy
Chaikin Money Flow: 32783 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 111.03) Buy
Bollinger Bands (100): (95.29 - 108.53) Buy

GNR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.76 Sell
20-day SMA: 60.98 Sell
50-day SMA: 59.87 Buy
200-day SMA: 55.93 Buy
8-day EMA: 61.54 Sell
20-day EMA: 61.11 Sell
50-day EMA: 59.1 Buy
200-day EMA: 37.38 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 110.65 Buy
20-day SMA: 107.3 Buy
50-day SMA: 106.17 Buy
200-day SMA: 82.91 Buy
8-day EMA: 44.16 Buy
20-day EMA: 20.28 Buy
50-day EMA: 8.6 Buy
200-day EMA: 2.21 Buy

SPDR S&P Global Natural Resources ETF Earnings Growth & GNR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

SPDR S&P Global Natural Resources ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):